.png){kind=icon}
-
Commercialization
Market Access and Phase IV Solutions
-
Informatics
Xcellerate® Trial Design Xcellerate® Monitoring Xcellerate® Insights GlobalCODE® Specimen TrackingConsulting & Partnering
Alliance Management Early Phase Development Solutions Covance MarketPlace Drug Development Consulting Access & Strategy Evidence GenerationClinical Development
Clinical Pharmacology Early Clinical / Phase IIa Phase IIb / III Services Clinical Data Management Analysis and Reporting Regulatory Services Phase IV Clinical Research Unit Virtual Tours Clinical-Biotech Decentralized Clinical Trials -
Functional Service Provider (FSPx)
FSP Education CenterClinical Testing
Flow Cytometry Solutions Central Laboratory Services Biomarker Solutions Biomarker Solution Center Translational Biomarker Solutions Companion Diagnostics Genomics Solutions Expanded Lab Management Solutions Vaccines & Novel Immunotherapeutics Personalized Study Performance ManagementCommercialization
Patient Support Services Phase IV Solutions Patient Safety and Pharmacovigilance Services Patient Support Services Resource Center
-
Call Us
The Americas
+1.888.COVANCE (+1.888.268.2623)1.609.452.4440Europe/Africa
+00.800.2682.2682+44.1423.500888Asia/Pacific
+800.6568.3000+65.6.5686588Global Office Locations
-
Media Relations
Request an InterviewRequest a SpeakerInvestigators
Kit OrderingInvestors
Investor RelationsJob Seekers
Covance Careers
Copyright © 2020 Covance Inc. All rights reserved.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.